首页 › 基金 › Eversept Partners, LP › LQDA
Eversept Partners, LP 对 LQDA 的持仓历史
LIQUIDIA CORPORATION · 医疗保健
Eversept Partners, LP 在 Q3 2026 的 13F 申报中披露持有 LQDA(LIQUIDIA CORPORATION)641,986 股,市值约 US$19.4M,约占其申报组合的 1.04%,在其申报持仓中市值排名第 27 位。 Eversept Partners, LP 最近 13 个申报季度中有 13 个季度披露了 LQDA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Eversept Partners, LP 对 LQDA 的持仓演变
Eversept Partners, LP 于 Q3 2023 首次披露 LQDA 持仓:1,395,454 股(约 US$8.8M)。 该持仓在 Q2 2026 达到峰值 428,652 股,市值约 US$34.2M。 在 13 次申报中,Eversept Partners, LP 6 次增持、6 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 641,986 股、市值约 US$19.4M,环比增持 213,334 股。。 持仓曾出现大幅变动:Q4 2024 增持约 314% (随后一个季度股价上涨 25%)、Q1 2025 减持约 74% (随后一个季度股价下跌 16%)、Q2 2025 增持约 138% (随后一个季度股价上涨 83%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.40M | $8.85M | 新进 |
| Q4 2023 | 688.93K | $8.29M | 减持 |
| Q1 2024 | 396.19K | $5.84M | 减持 |
| Q2 2024 | 373.55K | $4.48M | 减持 |
| Q3 2024 | 137.95K | $1.38M | 减持 |
| Q4 2024 | 571.30K | $6.72M | 增持 |
| Q1 2025 | 150.48K | $2.22M | 减持 |
| Q2 2025 | 358.83K | $4.47M | 增持 |
| Q3 2025 | 486.02K | $11.05M | 增持 |
| Q4 2025 | 509.44K | $17.57M | 增持 |
| Q1 2026 | 677.39K | $25.56M | 增持 |
| Q2 2026 | 428.65K | $34.18M | 减持 |
| Q3 2026 | 641.99K | $19.43M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LQDA 与 13F 数据
LQDA(LIQUIDIA CORPORATION)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 LQDA,申报仓位最大的包括:法拉龙资本管理 (US$666.9M), Caligan Partners LP (US$647.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$269.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LQDA 的基金
- 法拉龙资本管理 8.37M 股 · $666.94M · Q2 2026
- Caligan Partners LP 8.12M 股 · $647.32M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 8.91M 股 · $269.50M · Q3 2026
- Opaleye Management Inc. 2.45M 股 · $195.14M · Q2 2026
- Caprock Group, LLC 1.41M 股 · $112.40M · Q2 2026
- MPM BioImpact LLC 1.39M 股 · $110.52M · Q2 2026
- FINDELL CAPITAL MANAGEMENT LLC 1.30M 股 · $103.66M · Q2 2026
- Seven Fleet Capital Management LP 256.60K 股 · $20.46M · Q2 2026
- BOOTHBAY FUND MANAGEMENT, LLC 588.85K 股 · $17.82M · Q3 2026
- Sio Capital Management, LLC 282.00K 股 · $8.53M · Q3 2026
- Buckley Capital Advisors, LLC 278.90K 股 · $8.44M · Q3 2026
- Diametric Capital, LP 105.78K 股 · $8.43M · Q2 2026
更多关于 Eversept Partners, LP
常见问题
How long has Eversept Partners, LP held LQDA?
Eversept Partners, LP has disclosed LQDA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Eversept Partners, LP's current position in LQDA?
As of Q3 2026, Eversept Partners, LP holds 641.99K shares of LQDA (LIQUIDIA CORPORATION), valued at $19.43M, representing 1.04% of its reported portfolio and ranking #27.
Has Eversept Partners, LP been buying or selling LQDA?
In the latest 13F filing (Q3 2026), Eversept Partners, LP increased its position in LQDA. The position peaked in Q2 2026 at 428.65K shares.
Which other funds hold LQDA?
Other major institutional holders of LQDA include 法拉龙资本管理, Caligan Partners LP, FARALLON CAPITAL MANAGEMENT, L.L.C., among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.